Autophagy-Associated Immunogenic Modulation and Its Applications in Cancer Therapy

Cells. 2022 Jul 28;11(15):2324. doi: 10.3390/cells11152324.

Abstract

Autophagy, a lysosome-mediated cellular degradation pathway, recycles intracellular components to maintain metabolic balance and survival. Autophagy plays an important role in tumor immunotherapy as a "double-edged sword" that can both promote and inhibit tumor progression. Autophagy acts on innate and adaptive immunity and interacts with immune cells to modulate tumor immunotherapy. The discovery of autophagy inducers and autophagy inhibitors also provides new insights for clinical anti-tumor therapy. However, there are also difficulties in the application of autophagy-related regulators, such as low bioavailability and the lack of efficient selectivity. This review focuses on autophagy-related immunogenic regulation and its application in cancer therapy.

Keywords: autophagy; cancer therapy; immunity.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity
  • Autophagy / physiology
  • Homeostasis
  • Humans
  • Immunotherapy
  • Neoplasms* / metabolism

Grants and funding

This work is supported by the Natural Science Foundation of China (81872139 and 82072907); Project of The Beijing Xisike Clinical Oncology Research Foundation (Y-Roche2019/2-0078 and Y-pierrefabre202102-0107); Technology Development Program of Guangdong province (2021A0505030082); Project of The Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation (2020B1212060018).